Microsporidiosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Ahmed Younes (talk | contribs) No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The case-fatality rate of intestinal microsporidiosis is approximately 56% among HIV patients. The disease is present allover the world. | The [[Mortality rate|case-fatality rate]] of intestinal microsporidiosis is approximately 56% among [[HIV]] patients. The disease is present allover the world. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence:=== | ===Prevalence:=== | ||
*The overall prevalence is not accurately estimated especially in the whole population (because microsporidosis is usually investigated in immunocompromised patients with correlateing GI symptoms to microsporidosis). | *The overall [[prevalence]] is not accurately estimated especially in the whole population (because microsporidosis is usually investigated in [[Immunocompromised|immunocompromised patients]] with correlateing [[GI]] symptoms to microsporidosis). | ||
*In HIV patients with diarrhea, the prevalence of microsporidosis was 39% being the most common isolated organism. | *In [[HIV]] patients with [[diarrhea]], the [[prevalence]] of microsporidosis was 39% being the most common isolated organism. | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to the microsporidosis. | *There is no racial predilection to the microsporidosis. |
Revision as of 16:24, 1 July 2017
Microsporidiosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Microsporidiosis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Microsporidiosis epidemiology and demographics |
Risk calculators and risk factors for Microsporidiosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ogheneochuko Ajari, MB.BS, MS [2];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [3]
Overview
The case-fatality rate of intestinal microsporidiosis is approximately 56% among HIV patients. The disease is present allover the world.
Epidemiology and Demographics
Prevalence:
- The overall prevalence is not accurately estimated especially in the whole population (because microsporidosis is usually investigated in immunocompromised patients with correlateing GI symptoms to microsporidosis).
- In HIV patients with diarrhea, the prevalence of microsporidosis was 39% being the most common isolated organism.
Race
- There is no racial predilection to the microsporidosis.
Age
- Patients of all age groups may develop microspordosis.
Sex
- Males and females are affected equally by microsporidosis.
Geographic distribution
- Microsporidiosis infections occur worldwide with no geographic prediliction.